British Mitochondria Study Could Provide New Approaches to Treating ALS

Wave Is Developing Two Drugs That Target a Common ALS Mutation

Wave Life Sciences is developing two ALS and frontotemporal dementia therapies that target a gene mutation common in both. The therapies target mutations of the C9orf72 gene, Wave said in a business update. “I am excited to announce our next development program targeting C9orf72 mutations in ALS and FTD,” Dr.

Tips for Talking to Your Doctor

This Macmillan Cancer Support video shares some tips on how to get the best out of your doctor’s appointments and hospital visits. MORE: 7 ALS Facts You Might Find Interesting Dr. Davina Deniszczyc explains that before you meet with your doctor it’s a good idea to prepare a…

Robots, Technology, and A.I. — ‘Oh My!’

It seems to me that learning to live with ALS now requires a crash course in Technology 101. Gone are the days of having to rely solely on other human beings for essential daily living needs. Today, both the ALS patient and their caregiver are receiving help…